Antifibrotic therapy of liver cirrhosis, with special reference to primary biliary cirrhosis: promises and limitations

Neth J Med. 1992 Apr;40(3-4):209-14.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Liver Cirrhosis / drug therapy*
  • Liver Cirrhosis, Biliary / drug therapy
  • Ursodeoxycholic Acid / therapeutic use

Substances

  • Anti-Inflammatory Agents
  • Immunosuppressive Agents
  • Ursodeoxycholic Acid